Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Published on 16 Oct 2025

TACE combined with regorafenib with or without anti-PD-1 therapy for advanced HCC after targeted therapy failure: a multicenter real-world study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yan Li
Hang Yuan
Quan-Jun Yao
Xiang Geng
Fei Xu
Weijun Fan
Gang Wu
Guang-Shao Cao
Ho-Young Song
Hong-Tao Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1652319

642 views

Original Research

Published on 15 Oct 2025

A novel dynamic nomogram based on contrast-enhanced computed tomography radiomics for prediction of glypican-3-positive hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Chunlong Zhao
Zheyu Zhou
Jiarun Zhang
Shuya Cao
Jiawei Xu
Cheng Wang
Jun Chen
Xiaoliang Xu
Chaobo Chen
Bing Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1640697

391 views

Original Research

Accepted on 14 Oct 2025

Machine Learning-Based Identification of Core Regulatory Genes in Hepatocellular Carcinoma: Insights from Lactylation Modification and Liver Regeneration-Related Genes

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Rongchun Xing
Yu Yang
Yiwei Hou
Li Yi
Chongyuan Chen
Xiang Li
Yashan Wang
Yinxi Fu
Mingzheng Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1683704

162 views

Case Report

Accepted on 14 Oct 2025

Case report and review of the literature: Aggressive atypical cystic fibromatosis of the pancreas, a rare locally aggressive benign tumor

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xianhong Yang
Zhenji Xu
Yangyingqiu Liu
Tao Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1596535

Original Research

Accepted on 13 Oct 2025

Genetically Instrumented Circulating Metabolites and Hepatobiliary Cancer Risk: A Multi-tiered Mendelian Randomization and Functional Interrogation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lin Tuo
Li Ting Yan
Ying Liu
Shu Qiang Wang
Xiang An

Frontiers in Oncology

doi 10.3389/fonc.2025.1680865

Original Research

Accepted on 13 Oct 2025

Systemic Immune-Inflammation Index: A Key Biomarker Guiding Personalized Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xin Yin
Yanjiang Yin
Yanjiang Yin
Jinliang Tong
Yi Liu
Jianping Chang
Jindong Ma
Yaoyu Xie
Xin Li
Xiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1702336

103 views

Case Report

Accepted on 13 Oct 2025

Splenic Angiosarcoma With Hepatic and Cardiac Metastases: A Case Report and Literature Review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fang Zheng Chen
Fangzheng Chen
Haotian Yu
Shuai Wang
Yahao Wang
Lv Haitao

Frontiers in Oncology

doi 10.3389/fonc.2025.1682054

Case Report

Accepted on 10 Oct 2025

Unexpected Complete Remission After Recurrence in Pancreatic Cancer: A Case Report on Comprehensive Multimodal Therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Rihua He
Shangyou Zheng
Huimou Chen
Chonghui Hu
Tianhao Huang
Qing Lin
Honghui Jiang
Rufu Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1582673

197 views

Original Research

Published on 09 Oct 2025

Global burden and cross-country inequalities of gallbladder and biliary tract cancer in adults aged 45 years and older from 1990 to 2021: population-based study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Simeng Lei
Yangkai Fu
Bo Zhang
Hanwen Yang
Yang Hu
Zhili Ji

Frontiers in Oncology

doi 10.3389/fonc.2025.1676636

589 views

Original Research

Accepted on 08 Oct 2025

Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma after CT-guided Radiofrequency Ablation: Risk Factor Analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuyan Liu
Xiaoyang Zhao
Lupeng Li
Huicun Cao

Frontiers in Oncology

doi 10.3389/fonc.2025.1672300

108 views

Original Research

Accepted on 08 Oct 2025

Feasibility and Safety of Hepatic Artery Infusion Chemotherapy via the Distal Transradial access for hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wu Yi
Chunlin Yu
Xinghai Li
Baoliang Zhong
Daolin Zeng
Yunfei Tian

Frontiers in Oncology

doi 10.3389/fonc.2025.1644296

100 views

Case Report

Published on 08 Oct 2025

Case Report: Efficacy of preoperative conversion therapy with lenvatinib, toripalimab, and hepatic arterial infusion chemotherapy in an advanced hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jing Mao
Hengzhi Zhang
Xingxia Yang
Yanjun Yao
Xu Sun
Qiang Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1627281

820 views

Case Report

Published on 08 Oct 2025

Case Report: Giant cystic solid aggressive fibromatosis of the pancreas: clinical and pathologic features

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Runlin Feng
Tao Zhang
Lijuan Feng
Yanping Tao
Jiaping Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1634715

710 views

Review

Published on 06 Oct 2025

Immunohistochemistry in intrahepatic cholangiocarcinoma: histological subtyping and drug selection

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Han Wang
Miao-Xia He
Wen-Ming Cong
Hui Dong

Frontiers in Oncology

doi 10.3389/fonc.2025.1653534

1,037 views

Case Report

Published on 06 Oct 2025

Undifferentiated high-grade sarcoma with UES-like features in the retroperitoneum: a Case Report with TP53 p.R306 mutation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yinan Zhu
Mingfang Sun
Ziyue Wang
Xuyong Lin

Frontiers in Oncology

doi 10.3389/fonc.2025.1672264

669 views

Original Research

Published on 06 Oct 2025

Comparative analysis of external beam radiotherapy versus portal vein stent implantation combined with local and systemic therapy in hepatocellular carcinoma patients with portal vein tumor thrombus: a real-world retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wenping Luo
Guodong Wang
Shaojun Chen
Zhe Wang
Chuang Li
Chunwang Yuan
Jingsong Mao
Wenqi Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1671027

840 views